Erythrosine–Iron Oxide Nanoemulsions Combining Photodynamic Therapy with Ferroptosis-Mediated Cytotoxicity in Prostate Cancer
ACS Omega · 03.11.2026 · 11 (43) · 66772-66783
DOI: 10.1021/acsomega.6c05709 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 19.10.2026. Verfasst von Matheus Liberato Ferreira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioprocess and Biotechnology Engineering, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-901, …. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Erasmus+, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Prostate cancer remains one of the leading causes of cancer-related death among men worldwide. Photodynamic therapy (PDT) has emerged as a promising strategy to enhance conventional treatments, yet its efficacy is often limited by poor solubility, instability, and a lack of targeting of photosensitizers. Here, we report the development of hybrid erythrosine–iron oxide nanoemulsions (MNE/Ery) produced by vacuum-assisted nanoemulsification. The optimized formulation (0.05 mg·mL–1 erythrosine; 0.5 mg·mL–1 maghemite) exhibited a hydrodynamic diameter of ∼100 nm, negative surface charge, and strong retention of the photosensitizer’s spectral profile. The iron oxide nanoparticles (20–30 nm) exhibited efficient magnetic heating potential, reaching 42 °C within 5.5 min under an alternating field (418 kHz, 12 kA·m–1), indicating suitability for future exploration in magnetic hyperthermia applications. While MNE/Ery maintained high biocompatibility toward healthy cells (HDFn and PNT2), it induced a potent light-triggered cytotoxic response in PC-3 prostate cancer cells. Upon irradiation, the platform delivered a robust, dose-dependent therapeutic effect even at conservative fluences, driven by the combination of maghemite-induced oxidative stress (ferroptosis) and erythrosine-mediated ROS generation. These findings position the MNE/Ery system as a promising nanotechnological platform for PDT with an intrinsic iron-mediated chemotherapeutic effect, with additional potential for future magnetic hyperthermia-based applications.
Autor:innen und Institutionen
- Department of Bioprocess and Biotechnology Engineering, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-901, SP, Brazil.
- School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-901, SP, Brazil.
- Laboratory of Magnetic Materials and Colloids, Department of Physical Chemistry, Institute of Chemistry, São Paulo State University (UNESP), Araraquara 14800-060, SP, Brazil.
ORCID-Profile: Marlus Chorilli, Fernando Lucas Primo
Förderung
- Erasmus+
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Ferreira, M. L., Fortunato, G. C., Piazza, R. D., Chorilli, M., & Primo, F. L. (2026). Erythrosine–Iron Oxide Nanoemulsions Combining Photodynamic Therapy with Ferroptosis-Mediated Cytotoxicity in Prostate Cancer. ACS Omega, 11(43), 66772-66783. https://doi.org/10.1021/acsomega.6c05709
Vancouver
Ferreira ML, Fortunato GC, Piazza RD, Chorilli M, Primo FL. Erythrosine–Iron Oxide Nanoemulsions Combining Photodynamic Therapy with Ferroptosis-Mediated Cytotoxicity in Prostate Cancer. ACS Omega. 2026;11(43):66772-66783. doi:10.1021/acsomega.6c05709
BibTeX
@article{Ferreira2026,
author = {Ferreira, Matheus Liberato and Fortunato, Giovanna Capaldi and Piazza, Rodolfo Debone and Chorilli, Marlus and Primo, Fernando Lucas},
title = {Erythrosine–Iron Oxide Nanoemulsions Combining Photodynamic Therapy with Ferroptosis-Mediated Cytotoxicity in Prostate Cancer},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {43},
pages = {66772--66783},
doi = {10.1021/acsomega.6c05709}
}
EUVIMED